Meeder Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-199
| Closed | -$2K | – | 1003 |
|
|
2022
Q3 | $2K | Buy |
199
+7
| +4% | +$70 | ﹤0.01% | 1800 |
|
|
2022
Q2 | $1K | Buy |
192
+89
| +86% | +$464 | ﹤0.01% | 1992 |
|
|
2022
Q1 | $1K | Buy |
+103
| New | +$1K | ﹤0.01% | 2153 |
|
|
2021
Q4 | – | Sell |
-75
| Closed | -$1K | – | 1371 |
|
|
2021
Q3 | $1K | Buy |
+75
| New | +$1K | ﹤0.01% | 2290 |
|
|
2021
Q2 | – | Sell |
-5
| Closed | – | – | 2523 |
|
|
2021
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 2368 |
|
|
2020
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 1924 |
|
|
2020
Q3 | $0 | Sell |
5
-4,248
| -100% | – | ﹤0.01% | 2195 |
|
|
2020
Q2 | $77K | Sell |
4,253
-2,712
| -39% | -$49.1K | 0.01% | 820 |
|
|
2020
Q1 | $114K | Buy |
6,965
+4,696
| +207% | +$76.9K | 0.01% | 680 |
|
|
2019
Q4 | $40K | Buy |
2,269
+1,795
| +379% | +$31.6K | ﹤0.01% | 1089 |
|
|
2019
Q3 | $10K | Sell |
474
-16,258
| -97% | -$343K | ﹤0.01% | 1532 |
|
|
2019
Q2 | $369K | Buy |
+16,732
| New | +$369K | 0.03% | 459 |
|
|
2018
Q1 | – | Sell |
-99
| Closed | -$1K | – | 1587 |
|
|
2017
Q4 | $1K | Buy |
+99
| New | +$1K | ﹤0.01% | 1554 |
|
|
2017
Q2 | – | Sell |
-224
| Closed | -$5K | – | 1678 |
|
|
2017
Q1 | $5K | Buy |
224
+171
| +323% | +$3.82K | ﹤0.01% | 1057 |
|
|
2016
Q4 | $1K | Sell |
53
-466
| -90% | -$8.79K | ﹤0.01% | 950 |
|
|
2016
Q3 | $14K | Buy |
+519
| New | +$14K | ﹤0.01% | 700 |
|